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Background: Suicide and violence often co-occur in the general population as well as in mentally ill individuals.
Few studies, however, have assessed whether these suicidal behaviors are predictive of violence risk in mental
illness.
Aims: The aim of this study is to investigate whether suicidal behaviors, including suicidal ideation, threats, and
attempts, are signiﬁcantly associated with increased violence risk in individuals with schizophrenia.
Method:Data for these analyseswere obtained from the Clinical Antipsychotic Trials of Intervention Effectiveness
(CATIE) trial, a randomized controlled trial of antipsychotic medication in 1460 adults with schizophrenia. Uni-
variate Cox regression analyses were used to calculate hazard ratios (HRs) for suicidal ideation, threats, and at-
tempts. Multivariate analyses were conducted to adjust for common confounding factors, including: age,
alcohol or drug misuse, major depression, antisocial personality disorder, depression, hostility, positive symp-
tom, and poor impulse control scores. Tests of discrimination, calibration, and reclassiﬁcation assessed the incre-
mental predictive validity of suicidal behaviors for the prediction of violence risk.
Results: Suicidal threats and attemptswere signiﬁcantly associatedwith violence in bothmales and females with
schizophrenia with little change following adjustment for common confounders. Only suicidal threats, however,
were associated with a signiﬁcant increase in incremental validity beyond age, diagnosis with a comorbid sub-
stance use disorder, and recent violent behavior.
Conclusions: Suicidal threats are independently associated with violence risk in both males and females with
schizophrenia, and may improve violence risk prediction.tment of
: +44 18
. Open ac© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Schizophrenia is associated with signiﬁcantly elevated rates of both
suicide (Harris and Barraclough, 1997; Palmer et al., 2005; Saha et al.,
2007) and violence (Fazel et al., 2009a,b) compared to general popula-
tion rates. Although suicide and violence have historically been viewed
as distinct outcomes (Nock and Marzuk, 2000), several studies have
shown that suicide and violence often co-occur, both in the general pop-
ulation (Kennedy et al., 1999; Conner et al., 2001; Christoffersen et al.,
2005) and in mentally ill persons (Tardiff and Sweillam, 1980a,b;
Plutchik et al., 1986; Convit et al., 1988; Feinstein and Plutchik, 1990;
Apter et al., 1993; Asnis et al., 1994; Botsis et al., 1994; Apter et al.,
1995), including in those with psychosis (Cheng et al., 1990; Hunt
et al., 2006; Suokas et al., 2010). Most of this research, however, isPsychiatry, Warneford
65793101.
cess under CC BY-NC-ND licbased on cross-sectional studies and is dated. Closer scrutiny of this
association using longitudinal designs is therefore necessary.
While previous work suggests that suicide may be more closely as-
sociated with violent behavior in schizophrenia as compared to other
psychiatric disorders (Hunt et al., 2006), less work has investigated
the association between suicidality and violence in these individuals.
Attempts to address this question, moreover, have not provided clear
evidence of a signiﬁcant association as two systematic reviews have
reached divergent conclusions regarding whether violence predicts
suicide in those with schizophrenia (Hawton et al., 2005; Montross
et al., 2005).
We have therefore investigated the longitudinal association
between suicidality and violence in schizophrenia using the Clinical
Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset, a na-
tionally representative sample of 1460 participants with schizophrenia
treated under usual care conditions between 2001 and 2004. We also
investigated whether the association between violence and suicidality
is bi-directional by conducting two separate analyses in which violenceense.
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as violence and suicidality are known to share many common risk
factors (Conner et al., 2001), including: age (Conner et al., 2001), alcohol
misuse (Greenwald et al., 1994; Conner et al., 2001), symptoms of de-
pression (Apter et al., 1993), a diagnosis of antisocial personality
disorder (Verona et al., 2001), drug misuse (Greenwald et al., 1994),
gender (Tardiff and Sweillam, 1980a; Webb et al., 2011), impulsivity
(Apter et al., 1993), and positive symptomatology (Apter et al., 1993),
we conducted multivariate analyses to investigate whether any of
these potentially confounding factors moderates the association
between suicide and violence in schizophrenia.
2. Method
The data used in this study were collected as part of the National
Institute of Mental Health's (NIMH) CATIE study. The details of this
study have been reported elsewhere (Stroup et al., 2003, 2010). Brieﬂy,
the CATIE project was a multi-phase randomized controlled trial which
compared the effectiveness and tolerability of ﬁrst versus second gener-
ation antipsychotic medications (Stroup et al., 2003, 2010).
Between January, 2001 and December, 2004, 1493 males and
females diagnosed with schizophrenia were recruited to participate in
the CATIE project (Perlick et al., 2010). Due to concerns over quality,
however, data from one site (n = 33) were excluded, leaving a total
sample of 1460 participants. The present study is therefore based on
information from these 1460 participants.
The project consisted of four phases. In the ﬁrst, individuals were
randomized to treatment with the typical antipsychotic perphenazine
or one of three atypical antipsychotics: olanzapine, quetiapine, or
risperidone (Stroup et al., 2003, 2010). Subsequent to Food and Drug
Administration (FDA) approval in February 2001, participants could
also be randomized to treatment with ziprasidone (Stroup et al., 2003,
2010). Only participants with a history of tardive dyskinesia were
ineligible for randomization to perphenazine (Stroup et al., 2003,
2010). In phase 1B, individuals who refused or discontinued treatment
with perphenazine in phase 1 of the CATIE project were randomly
reassigned to treatment with olanzapine, quetiapine, risperidone, or
ziprasidone (Stroup et al., 2003, 2010).
In phase 2 of theproject, participantswhohad refused or discontinued
any trial medication in phase 1 or 1B due to a lack of effect were
prescribed either open-label treatment with clozapine, or, were random-
ized to treatmentwith olanzapine, quetiapine, risperidone, or ziprasidone
(Stroup et al., 2003, 2010). On the other hand, participants who had re-
fused or discontinued anymedication due to the development of intoler-
able side-effects were randomized to olanzapine, risperidone, quetiapine,
or ziprasidone (Stroup et al., 2003; Citrome and Stroup, 2006; Stroup
et al., 2006; Swartz et al., 2008; Stroup et al., 2010). Lastly, in phase 3 of
the project, participants who had refused or discontinued medications
at any point in the trial could receive treatment with one of eight open-
label medications, or with a combination of any two of thesemedications
(Stroup et al., 2003, 2009; van der Oord et al., 2009; Stroup et al., 2010).
While the primary outcome of the CATIE trial was treatment discon-
tinuation for any reason (Stroup et al., 2003, 2010), as part of the trial
participants underwent frequent and detailed clinical assessments en-
abling information to be collected on a number of secondary outcomes,
including the occurrence of adverse events such as suicide and violence
(Stroup et al., 2009). The clinical data are widely available via the
controlled-access repository of the NIMH (van der Oord et al., 2009).
2.1. Violence
As previous work suggests that reliance on self-reported incidents
may cause the true extent of violence in this population to be
underestimated (Swanson et al., 2006), for the purposes of this study
violence was ascertained from the follow-up family interviews.To identify whether risk factors for suicidality are predictive of vio-
lence in individuals with schizophrenia, only reports of violence perpe-
tration made from the date of the six-month interview onward were
coded for information regarding violent behavior. Additionally, where
an individual had more than one positive report of violence, we coded
violence from the report made closest to the end of the follow-up
period. This ensured that the violent episode was more likely to have
occurredwhen the participant was stabilized on one of the trialmedica-
tions which, in turn, minimizes the impact of treatment non-adherence
as a potentially confounding factor in any association.
2.2. Suicidality phenomena
Three suicidal phenomena were examined: ideation, threats, and
attempts. In line with the Centers for Disease Control (CDC) uniform
deﬁnitions (Crosby et al., 2011), suicidal ideation was deﬁned as
thoughts of engaging in suicidal behavior with or without a deﬁnitive
plan but with no evidence of current suicidal behavior. A positive rating
of suicidal ideation was coded from a rating of ‘mild’ or ‘moderate’ on
the suicide item of the Calgary Depression Rating Scale (CDRS;
Addington et al., 1993) or from a record of suicidal ideation on the
CATIE Serious Adverse Events (SAE) record form.
Although use of the term suicidal threat is discouraged by the CDC
uniform deﬁnitions, this termwas preserved in the current study to re-
ﬂect that adopted by the original CATIE trial authors. Suicidal threats
were coded from family informant information provided at either the
baseline or six monthly follow-up interviews.
Suicide attempt is deﬁned by the CDC as non-fatal behavior with the
potential for injury or death coupled with suicidal intent (Crosby et al.,
2011). Suicide attempts were coded from a rating of ‘severe’ on the sui-
cide item of the CDRS, a positive response on the baseline or follow-up
family interview, or from the SAE record form. Overdose was coded
from the SAE record form, while deliberate self-harm was coded from
the baseline or follow-up family interview and from the SAE record form.
2.3. Potential confounding factors
A number of baseline demographic factors were investigated for
their effect on the association between suicidal behavior and violence,
including: age, duration of illness, health insurance status (as a proxy
for socio-economic status), non-White ethnicity, educational status,
and number of prior psychiatric admissions. Information on these fac-
tors was extracted from the CATIE screening questionnaire.
Alcohol misuse was coded from a clinician rating of alcohol abuse,
dependence, or dependence necessitating inpatient care according to
the Clinical Global Impression Scale (CGIS; Guy, 1976), a family report
of excessive alcohol use at the baseline or follow-up interview, a record
of alcohol abuse or dependence according to the SCID, or from a
record of alcohol abuse or dependence according to the screening
questionnaire.
Drug misuse was similarly coded from the CGIS, a family report of
drug use at the baseline or follow-up interview, a record of abuse or de-
pendence according to the SCID, or from the screening questionnaire. A
positive test for cocaine, opiates, phencyclidine, methamphetamines, or
cannabis according to hair strand analysis was also included as evidence
of drug misuse.
Depression was coded continuously, from total scores on the CDRS,
and categorically from the SCID or the screening questionnaire. A life-
time diagnosis of Antisocial Personality Disorder (ASPD) was coded
from the screening questionnaire.
Positive symptomatology, hostility, and poor impulse control scores
were coded from the Positive andNegative SymptomScale (PANSS; Kay
et al., 1987). As the PANSS was administered at several different time
points throughout the CATIE trial (Stroup et al., 2010), scores were
coded at both baseline and at six month follow-up. At baseline,
participants had not yet entered the CATIE project. Therefore scores
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medication adherence was not being monitored. After six months of
participation, however, medication adherence had been monitored
and therefore scores on these measures are likely to reﬂect each
individual's highest level of functioning.
2.4. Statistical analyses
Individuals were followed from baseline until a positive rating for
violence, withdrawal from the study, death, or end of the follow-up
period (December 4, 2004). To determine whether the association
was bi-directional, violence was also investigated as an exposure. In
this analysis, individuals were followed from baseline until observance
of suicidal phenomena, withdrawal, death, or the end of the follow-up
period (December 4, 2004).
Cox regression was used to investigate both associations. Cox re-
gression generates hazard ratios (HRs) and accompanying 95% conﬁ-
dence intervals (CIs) which represent the ratio of the event rate. The
proportional hazards assumption was assessed visually using plots of
the smoothed Schoenfeld residuals. Proportionality was inferred as
presentwhen the line formed by these residualswas roughly horizontal
(Kleinbaum and Klein, 2012). Using this approach, there was no strong
evidence that the proportionality assumption was violated for any of
risk factors investigated.
Univariate associations were calculated separately for males and fe-
males. Multivariate associations were then calculated to investigate
whether any association between violence and suicidal ideation,
threats, and attempts was modiﬁed by age, alcohol or drug misuse, a
lifetime diagnosis of major depression, a lifetime diagnosis of ASPD,
depression scores, hostility scores, positive symptoms scores, or poor
impulse control scores.
In addition to being signiﬁcantly associated with the outcome of
interest, an important risk factor must also demonstrate improvement
in discrimination, calibration, and reclassiﬁcation (Ioannidis and
Tzoulaki, 2010). Discrimination, which refers to the ability of a model
to distinguish between those who do and do not experience the
event of interest, was assessed using Harrell's c-index (Pencina and
D'Agostino, 2004). The c-index varies from 0.5 to 1.0, with 1.0 suggest-
ing perfect discrimination (Wood and Greenland, 2009). The c-index
has a similar interpretation to the area under the receiver operating
curve (AUC) but is more appropriate for survival data characterized by
censored observations (Nead et al., 2013). Calibration, which examines
goodness of ﬁt, was assessed statistically using the Grønnesby and
Borgan test (Grønnesby and Borgan, 1996). Change in Royston's R2
was used to assess reclassiﬁcation, which refers to the ability of a
novel risk factor to improve the percentage of variance explained by
the risk model (Royston and Sauebrei, 2004; Royston, 2006).
In incremental predictive validity analyses, all risk factors were ad-
justed for age, a lifetime diagnosis for a substance use disorder (SUD),Table 1
Demographic and clinical characteristics of the CATIE population measured at randomization.
Demographic and clinical characteristics measured at baseline Gender
Males
Mean
Age (years) 40.0
Median
Number previous psychiatric admissions over lifetime 4
Duration of illness (years)1 13
N
Non-White ethnicity (yes/no) 403
Health insurance status (Medicare or Medicaid/Private) 974
Not completed high school education (yes/no) 266
Note: SD= standard deviation; IQR = interquartile range.
1 Measured as the number of years between ﬁrst prescription for any antipsychotic medicatandprevious violence. These factorswere chosen as they have been pre-
viously shown to be strongly associated with violence risk in those with
schizophrenia (Swanson et al., 2006; Fazel et al., 2009a,b). All analyses
were conducted using Stata, version 11 (StataCorp, 2007).
3. Results
There were 1080 (73.9%) males and 380 (26.0%) females. Mean age
at randomization was 40.6 yr (SD= 11.1, range 18 to 67). All partici-
pants were diagnosed with schizophrenia according to DSM-IV criteria,
and were typically moderately ill (Caroff et al., 2010). Further demo-
graphic information is available in Table 1.
3.1. Suicidal behavior as a risk factor for violence
The median length of follow-up was 15.7 months (Inter-quartile
range [IQR] 4.6 to 16.8). Around half (n= 666; 45.6%) withdrew from
the CATIE study before all 18 months of follow-up had been completed.
Five (0.3%) participants died during the analysis period: 2 from suicide,
and one each from cardiac arrest, convulsions, and hypertensive heart
disease.
A total of 121 (8.3%) participants were rated as violent at least once
during the CATIE trial. The majority of these individuals were male
(n = 97; 80.1%; females n= 24; 19.9%). With regard to the suicidality
factors investigated, 493 (33.7%) experienced suicidal ideation, 162
(11.1%) threatened suicide, and 85 (5.8%) attempted suicide.
In univariate analyses, two suicidality factors were signiﬁcantly as-
sociated with violence in males: suicidal threats (HR = 3.8, 95% CI
2.4–6.0) and attempts (HR = 2.8, 95% CI 1.5–5.4). For females, suicidal
threats (HR = 9.4, 95% CI 4.0–21.6) and attempts (HR = 4.4, 95% CI
1.5–12.7) were also signiﬁcantly associated with violence. In neither
gender, however, was suicidal ideation signiﬁcantly associated with vi-
olence (Table 2).
In relation to the potential confounders, a total of 485 (33.2%) partic-
ipants had a history of alcohol misuse (males: n=407, 37.6%; females:
n=78, 20.5%), 709 (48.5%) had a history ofmisusing drugs (males: n=
564, 52.2%; females: n=145, 38.1%), 420 (28.7%) had a lifetimediagno-
sis of major depression (males: n = 291, 26.9%; females: 129, 33.9%),
and 17 (1.1%)were diagnosedwith ASPD (males: n=15, 1.3%; females:
n=2, 0.5%). Adjustment for these factors did not materially change the
associations between suicidality and violence for males or females
(Table 3).
There were also no material changes to the associations between
suicidality and violence following adjustment for age, baseline depres-
sion, hostility, positive symptomatology, or poor impulse control scores
in either gender (Table 4). Additionally, no differencewas found follow-
ing adjustment for six month scores on these measures for females.
However, adjustment for sixmonth scores did cause the association be-
tween suicidal attempts and subsequent violence to become non-Females
SD Mean SD
11.3 42.2 10.3
IQR Median IQR
(2.0–4.0) 3 (1.0–4.0)
(4.0–23.0) 13 (5.5–21.0)
% N %
37.3 181 47.8
91.3 333 89.8
24.6 108 28.4
ion until randomization into the CATIE trial.
Table 2
Univariate hazard ratios (HRs) for the risk of violent behavior in males and females with schizophrenia.
Gender Risk factor n Violent n Non-violent HR (95% CI) z p
With Without With Without
Males
Suicidal ideation 34 63 321 662 1.0 (0.7–1.5) 0.1
Suicidal threats 31 66 79 904 3.8 (2.4–6.0) 5.9 ⁎⁎⁎
Suicide attempt 13 84 47 936 2.8 (1.5–5.4) 3.2 ⁎⁎
Females
Suicidal ideation 4 20 134 222 0.3 (0.1–1.2) −1.7
Suicidal threats 14 10 38 318 9.4 (4.0–21.6) 5.2 ⁎⁎⁎
Suicide attempt 5 19 20 336 4.4 (1.5–12.7) 2.8 ⁎⁎
Note:
⁎⁎⁎ Signiﬁcant to the 0.001 level.
⁎⁎ Signiﬁcant to the 0.01 level.
⁎ Signiﬁcant to the 0.05 level.
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tics assessed, including: duration of illness, health insurance status,
non-White ethnicity, educational status, and number of prior psychiat-
ric admissions, materially changed the association between suicidal be-
havior and violence either gender (Table S1).
For both males and females, a previous suicidal threat was associat-
ed with the largest increase in both Harrell's c-index and Royston's R2,
suggesting that the addition of suicidal threats to a baseline risk model
comprising age, comorbid SUD, and previous violence improves thepre-
diction of subsequent violence. This adjusted model was also well cali-
brated, as indicated by a non-signiﬁcant Grønnesby–Borgan test,
suggestive of good ﬁt (Table 5).3.2. Violent behavior as a risk factor for suicidal phenomena
The median length of follow-up for this analysis was 10.8 months
(IQR 2.8 to 16.6). Again, around half of the sample withdrew prior to
successful completion of the full 18 month follow-up period (n =
698; 47.8%). Three (0.2%) participants died during this analysis period:
one each from hypertensive heart disease, convulsions, and suicide.
Suicidal ideation, threats, or attempts were observed in 470 (32.2%)
participants. Suicidal participantsweremostlymale (n=331, 70.4%; fe-
males: n = 139, 29.5%). With regard to violence, 196 (28.8%) partici-
pants were rated by a family member as having behaved violently.
Univariate analyses showed no association between a history of vio-
lence and subsequent suicidal phenomena in males (HR = 1.3, 95% CI
0.9–1.8, p= 0.10) or females (HR = 1.0, 95% CI 0.6–1.6, p= 0.93).Table 3
Multivariate hazard ratios (aHRs) for the risk of violent behavior in males and females with sc
Gender Risk factor Alcohol misuse Drug misuse
aHR (95% CI) aHR (95% CI)
Males
Suicidal ideation 0.9 (0.6–1.4) 0.9 (0.6–1.4)
Suicidal threat 3.4 (2.2–5.3) ⁎⁎⁎ 3.9 (2.5–6.1) ⁎⁎⁎
Suicide attempt 2.8 (1.5–5.4) ⁎⁎ 2.8 (1.5–5.4) ⁎⁎
Females
Suicidal ideation 0.3 (0.1–1.1) 0.3 (0.1–1.1)
Suicidal threat 8.6 (3.7–19.8) ⁎⁎⁎ 9.4 (4.0–21.8) ⁎⁎⁎
Suicide attempt 4.0 (1.4–11.3) ⁎⁎ 4.3 (1.4–12.7) ⁎⁎
Note: MDD= Major Depression Disorder; ASPD = Antisocial Personality Disorder; Any como
⁎⁎⁎ Signiﬁcant to the 0.001 level.
⁎⁎ Signiﬁcant to the 0.01 level.
⁎ Signiﬁcant to the 0.05 level.4. Discussion
The longitudinal association between suicidality and violent behav-
ior was investigated in 1460 participants diagnosedwith schizophrenia,
recruited between 2001 and 2004 as part of the NIMH CATIE project.
Strong associations with violence were found for suicidal threats and
attempts in both males and females. Suicidal ideation, however, was
not associated with violence in either this study or in a previous meta-
analysis of risk factors for violence in psychosis (Witt et al., 2013). One
reason may be that suicidal ideation is extremely common in this pop-
ulation (Kontaxakis et al., 2004). Alternatively it may be that while vio-
lence is associated with more behavioral forms of suicidality, such as
attempted suicide, it is not related to suicidal ideation, as has previously
been shown in prisoner populations (Sarchiapone et al., 2009; Zhang
et al., 2010). In line with this, recent work suggests that impulsivity
could mediate the association between suicidal behavior and violence,
thereby explainingwhy impulsive suicidal behaviors, such as attempted
suicide, are more strongly associated with violence risk than suicidal
ideation (Witt et al., 2013).
Furthermore, although previous work suggests that confounding
factors such as age, alcohol misuse, anger and/or hostility, ASPD, major
depression, and drug misuse may account for the association between
violence and suicidality, in multivariate analyses we found no evidence
that these factors confounded the relationship in either gender.With re-
gard to confounding factors measured continuously, while adjustment
for baseline depression, hostility, positive symptom, and impulse con-
trol scores resulted in no material changes to the associations for
males or females, adjustment for six month scores on these measureshizophrenia adjusted for categorical confounding factors.
Diagnosis of MDD Diagnosis of ASPD Any comorbidity
aHR (95% CI) aHR (95% CI) aHR (95% CI)
1.0 (0.6–1.5) 1.0 (0.7–1.5) 0.9 (0.6–1.4)
3.8 (2.4–6.0) ⁎⁎⁎ 3.8 (2.4–6.0) ⁎⁎⁎ 3.8 (2.5–5.9) ⁎⁎⁎
2.8 (1.4–5.4) ⁎⁎ 2.8 (1.5–5.3) ⁎⁎ 2.8 (1.5–5.4) ⁎⁎
0.3 (0.1–1.2) 0.3 (0.1–1.2) 0.3 (0.1–1.1)
9.3 (3.9–21.9) ⁎⁎⁎ 9.3 (4.0–21.5) ⁎⁎⁎ 9.4 (4.0–21.9) ⁎⁎⁎
4.5 (1.5–13.2) ⁎⁎ 4.4 (1.5–12.6) ⁎⁎ 4.4 (1.5–12.9) ⁎⁎
rbidity = diagnosed with any one of these four comorbid conditions.
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65K. Witt et al. / Schizophrenia Research 154 (2014) 61–67resulted in some moderation of the association between suicidal
attempts and violence in males. We suggest that this ﬁnding implies
that levels of symptomatology while compliant with medication may
be an important predictor of violence risk. Adjusting for other baseline
factors, including duration of illness, health insurance status, non-White
ethnicity, educational status, and number of prior psychiatric admissions,
also did not moderate the association between suicidal behavior and
violence in this population.
Reclassiﬁcation analyses reveal that the addition of suicidal threats
increases Royston's R2 by 13.4% in males and 44.1% in females. Change
in discrimination, as measured by Harrell's c-index, was signiﬁcant for
men, and approached signiﬁcance in women. Few violence risk assess-
ment instruments currently include an assessment of suicidal behavior,
however (Witt et al., 2013). Results of this study therefore suggest that
the inclusion of an item assessing threatened suicide should be consid-
ered for existing violence risk assessment instruments.
It is unclearwhether the association between threatened suicide and
violence is speciﬁc to schizophrenia, however. We therefore conducted
a systematic review of the PUBMED database covering the last 5 years
(1 January, 2009 to 31 December, 2013) and found no other work that
addressed the association between threatened suicide and risk of vio-
lence perpetration. Furtherwork on this question is therefore necessary.
A history of violent behavior was not signiﬁcantly associated with
suicidal phenomena in either gender, in line with ﬁndings of earlier
meta-analyses of factors associatedwith risk of suicidal behavior in peo-
ple with schizophrenia (Hawton et al., 2005), but in contrast with those
of another systematic review (Montross et al., 2005). The association
with completed suicide, however, could not be examined due to a lack
of statistical power. Previous epidemiological work, however, suggests
a signiﬁcant association between criminal history and completed sui-
cide in the general population (Webb et al., 2011).
4.1. Implications
Two implications follow from these ﬁndings. First, as part of the clin-
ical risk assessment of violence in schizophrenia, as recommended by
clinical guidelines in both the US and UK, a careful examination of histo-
ry of suicidality should be included. Second, the association between
suicidal attempts and violence may be modiﬁed by six month depres-
sion, hostility, positive symptomatology, and poor impulse control
scores in males. Given that medication adherence was monitored dur-
ing the CATIE trial, this ﬁndingmay suggest that acute symptomatology,
perhaps exacerbated by medication non-adherence, may account for
some of the association between suicidality and violence in males. Pre-
vious work has, for example, shown that treatment non-adherence is
signiﬁcantly associated with increased suicide (Hawton et al., 2005)
and violence (Witt et al., 2013) risk in this population. Efforts to im-
prove medication adherence may therefore lead to a reduction in both
behaviors.
4.2. Strengths
A variety of measures were used to assess exposure to suicidality
and violence in this study, including a combination of both self-report,
informant report, and psychometric tools. Given the limitations inher-
ent in self-report and informant-report data in isolation, the use of
both data sources in combinationmay have led to a more accurate indi-
cation as to the extent of both suicidality and violence in this study com-
pared to previous investigations.
Secondly, few exclusion criteria were used to prevent participation
of sub-groups of schizophrenia patients who are often excluded from
other RCTs, including those with treatment refractory disorders, those
who had experienced multiple symptomatic exacerbations, those with
a history of medication non-adherence (Hofer et al., 2000), and those
with comorbid conditions, or substance misuse (Gilbody et al., 2002).
Table 5
Multivariate hazard ratios (aHRs) and incremental predictive validity analyses for the risk of violent behavior in males and females with schizophrenia.
Gender Risk factor aHR (95% CI) z p Harrell's c-index Grønnesby–Borgan χ2 test Adjusted Royston's R2
% (95% CI) Δ (%) p χ2 p Δχ2 Δp % (95% CI) Δ (%)
Males
Baseline model 70.2 (65.7–74.7) 10.9 ⁎⁎ 22.2 (12.6–34.9)
+ Suicidal threats 3.4 (2.1–5.6) 5.0 ⁎⁎⁎ +5.3 ⁎⁎ −8.6 +0.13 +13.4
+ Suicidal attempts 2.3 (1.1–4.7) 2.3 ⁎ +1.5 −6.6 +0.14 +2.9
Females
Baseline model 67.3 (62.0–72.7) 1.6 0.20 26.7 (3.7–82.4)
+ Suicidal threats 10.4 (4.2–25.7) 5.1 ⁎⁎⁎ +3.3 −1.6 +0.71 +44.1
+ Suicidal attempts 4.1 (1.5–11.4) 2.8 ⁎⁎ +0.6 −1.6 +0.70 +10.3
Note: Baseline model composed of age at randomization, diagnosis of comorbid substance use disorder, and recent violent behavior in the six months preceding randomization to the
CATIE project. Change in Harrell's c-index, the Grønnesby–Borgan χ2 test, and adjusted Royston's R2 is assessed with reference to this baseline model. The overall Harrell's c-index,
Grønnesby–Borgan χ2 test, and adjusted Royston's R2 is calculated for the baseline model alone.
⁎⁎⁎ Signiﬁcant to the 0.001 level.
⁎⁎ Signiﬁcant to the 0.01 level.
⁎ Signiﬁcant to the 0.05 level.
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Previous research does, however, suggest that RCTs of antipsychotic
effectiveness in schizophrenia are less likely to recruit individuals
reporting thoughts of suicidality and deliberate self-harm (Gilbody
et al., 2002). Consequently, the results of this study may not generalize
to all patients with schizophrenia. Nevertheless, the CATIE trial used
wide inclusion criteria to recruit a diverse range of participants treated
under usual care conditions (Stroup et al., 2003).
Second, the CATIE data were not collected speciﬁcally to meet the
aims of this study. Therefore, a number of potentially relevant con-
founding factors could not be included in the multivariate analyses, in-
cluding intelligence scores (Webb et al., 2011) and neighborhood socio-
economic deprivation (Kennedy et al., 1999). Additionally, although
previouswork identiﬁes anger and impulsivity as potential confounders
(Apter et al., 1993), these factors were not speciﬁcally assessed. Instead,
anger and impulsivity had to be coded from the hostility and poor im-
pulse control items of the PANSS. Previous work, however, suggest
that impulsivity consists of both a behavioral and cognitive component
(Winstanley et al., 2006; Broos et al., 2012). The impulse control itemon
the PANSS, in contrast, reﬂects only the behavioral component of impul-
sivity. Further research should determine whether measures which re-
ﬂect the cognitive component of impulsivity may account for the
association between suicidality and violence.
Anger and hostility also appear to be conceptually distinct (Eckhardt
and Barbour, 1997). Whereas anger reﬂects an emotion elicited by cir-
cumstances, hostility implies a cognitive belief concerning the inten-
tions of others (Sanz et al., 2010). Future work is therefore necessary
to determinewhether it is the emotional component of angerwhich un-
derlies any association between suicidality and violence.
Lastly, around half of the participants originally enrolled in the CATIE
trial withdrew before all 18 months of follow-up were completed.
Adjusting for completion status did not materially affect the association
between suicidal threats and violence in this study, however (results
not shown). Additionally, work indicates that loss to follow-upwas sim-
ilar between treatment groups in the CATIE trial (Rosenheck and Leslie,
2010).4.4. Conclusions
This study demonstrated that suicidal threats and attempts where
signiﬁcantly associated with an increased risk of violent behavior in a
sample of 1460males and femaleswith schizophrenia. Suicidal ideation,
however, was not signiﬁcantly associatedwith violence.When analyses
were adjusted for alcohol misuse, drug misuse, major depression, orASPD, the association was not materially different. Similarly, when haz-
ards for violence were adjusted for age, depression, hostility, positive
symptomatology, or poor impulse control scores, therewas little change
in the association between suicidal ideation, threats, or attempts and vi-
olence. Results of this study therefore suggest that certain suicidal be-
haviors, and suicidal threats in particular, may represent an
independent risk factor for violence in schizophrenia.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.schres.2014.02.001.
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